Cite
MLA Citation
M. Iastrebner et al.. “Clinical-Risk Factors that Influence an Optimal Hypomethylating Agents Treatment in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia.” Leukemia research, vol. 55, n.d., pp. S64–. http://access.bl.uk/ark:/81055/vdc_100045920464.0x000006